CKS is no longer commissioned by the National Institute for Health and Clinical Excellence (NICE). NICE remains committed to providing a replacement service for CKS and is currently reviewing its options. In the meantime, although CKS content is now not being maintained, it still remains relevant and will continue to be made available. CKS content was generated under a programme of topic creation and update. To check if the topic you are viewing is current or out of date, please refer to the topic publication details by clicking on the 'How up-to-date is this topic?' link in the left hand menu on individual topic pages.
Palliative cancer care - oral problems - Management
Corticosteroids
- As corticosteroid use for aphthous ulcers is short-term, potential problems often associated with corticosteroid use (e.g. osteoporosis) are not relevant.
- Beclometasone spray or betamethasone soluble tablets are more potent than hydrocortisone lozenges, but they have an increased risk of systemic adverse effects and oral candidiasis. They are generally reserved for use when ulceration is extensive or at a difficult-to-reach site.
© NHS Institute for Innovation and Improvement